Showing results (501-510 of 991) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|June 1, 2019
Analysis and Quantification of Oxidized Low-Density Lipoprotein-Induced Lipid Droplets in Macrophages Through High-Content Screening: Application for Antiatherogenic Drugs DiscoveryLeo Tsui, I-Jong Wang
Assay and Drug Development Technologies|January 3, 2023
Design, Synthesis, and Biological Evaluation of Novel Dihydropyrimidinone Derivatives as Potential Anticancer Agents and Tubulin Polymerization InhibitorsRamkaran Rawal, Praveen K Gupta, Bhupinder Kumar, et al.
Assay and Drug Development Technologies|September 17, 2009
Conformational mAb as a tool for integrin ligand discoveryBen H Njus, Alexandre Chigaev, Anna Waller, et al.
Assay and Drug Development Technologies|February 2, 2011
Efficient in silico assay of inhibitors of hepatitis C Virus RNA-dependent RNA polymerase by structure-based virtual screening and in vitro evaluationYing-Ting Lin, Kuo-Jung Huang, Chin-Kai Tseng, et al.
Assay and Drug Development Technologies|December 17, 2010
The eighth annual ion channel retreat, Vancouver, Canada, June 28-30, 2010Saranna Brugger, Susannah Kennedy, Lucie Semenec, et al.
Assay and Drug Development Technologies|December 17, 2010
Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery settingXi-Ping Huang, Thomas Mangano, Sandy Hufeisen, et al.
Assay and Drug Development Technologies|December 17, 2010
Profiling diverse compounds by flux- and electrophysiology-based primary screens for inhibition of human Ether-à-go-go related gene potassium channelsBeiyan Zou, Haibo Yu, Joseph J Babcock, et al.
Assay and Drug Development Technologies|December 29, 2010
Primary cells and stem cells in drug discovery: emerging tools for high-throughput screeningRichard Eglen, Terry Reisine
Assay and Drug Development Technologies|September 1, 2010
Identification of substrates of SMURF1 ubiquitin ligase activity utilizing protein microarraysPaul S Andrews, Steve Schneider, Evelyn Yang, et al.
Assay and Drug Development Technologies|November 6, 2010
Using a genetically encoded fluorescent amino acid as a site-specific probe to detect binding of low-molecular-weight compoundsIsaac N Ugwumba, Kiyoshi Ozawa, Laura de la Cruz, et al.
Pageof 100